Group-based IMPROVE Therapy for Problematic Internet Use in University Students
IMPROVE-PIU
Effectiveness and Psychological Mechanisms of Group-based IMPROVE Therapy for Problematic Internet Use in University Students: A Single-blind Randomized Controlled Trial
2 other identifiers
interventional
600
1 country
2
Brief Summary
Problematic internet use (PIU) is a growing behavioral health concern among university students. This study aims to evaluate the effectiveness and psychological mechanisms of "IMPROVE," a manualized, multimodal group-based psychotherapy. The IMPROVE program integrates cognitive-behavioral strategies with motivational elements, mindfulness training, and socially interactive exercise. In this randomized controlled trial, 600 university students with moderate to severe PIU will be randomized to either the 8-week IMPROVE intervention or an enhanced waitlist control group. The primary outcome is the change in PIU severity, assessed by the Internet Addiction Test (IAT) score, from baseline to the post-intervention endpoint (8 weeks).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedStudy Start
First participant enrolled
March 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
August 5, 2026
December 1, 2025
1.2 years
February 12, 2026
August 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Problematic Internet Use Severity (IAT Score)
Assessed using the Internet Addiction Test (IAT). Scores range from 20 to 100, with higher scores indicating greater severity. The primary endpoint is the change from baseline to post-intervention
Baseline (T0) and Post-intervention (Week 8, T2)
Secondary Outcomes (25)
Long-term Change in PIU Severity (IAT)
Month 1 (T3), Month 3 (T4), Month 6 (T5), and Month 12 (T6) Follow-up
Participant Satisfaction and Acceptability
Post-intervention at Week 8 (T2)
Smartphone Addiction Risk (SAS-SV)
Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Internet-use Disorder severity based on ICD-11 criteria (ACSID-11)
Baseline (T0), Post-intervention at Week 8 (T2), Month 3 (T4), and Month 12 (T6) Follow-up
Internet Usage Duration
Baseline (T0), Week 4 (T1), Week 8 (T2), Month 1 (T3), Month 3 (T4), Month 6 (T5), and Month 12 (T6) Follow-up.
- +20 more secondary outcomes
Other Outcomes (2)
Collection of neuroimaging data for exploratory analyses
Baseline (T0) and Post-intervention at Week 8 (T2)
Collection of peripheral blood samples for exploratory biomarker analyses
Baseline (T0) and Post-intervention at Week 8 (T2)
Study Arms (2)
IMPROVE Intervention Group
EXPERIMENTALParticipants receive IMPROVE therapy delivered in groups over 8 weeks, with 120 minutes per week (8 sessions total). The program integrates cognitive-behavioral strategies with motivational elements, mindfulness training, and socially interactive exercise. Sessions will be delivered by trained therapists using a standardized intervention manual, with regular weekly supervision to support consistency of intervention delivery.
Enhanced Waitlist Control (EWC) Group
OTHERParticipants will receive one standardized digital newsletter per week via WeChat during the initial 8-week intervention period (T0-T2). They will then remain on the waitlist until completion of the 3-month follow-up assessment (T4), after which they will be offered the full 8-week IMPROVE intervention.
Interventions
A manualized, group-based, multimodal integrative psychotherapy. It integrates CBT-informed strategies, Mindfulness-Based Interventions, and Socially Interactive Exercise. Delivered over 8 weekly sessions (120 minutes each). Groups consist of 10-15 participants
Weekly newsletters pushed via WeChat containing psychoeducation on consequences of internet use and general advice for reducing screen time.
Eligibility Criteria
You may qualify if:
- be university students aged between 18 and 30 years;
- report subjective suffering regarding their own internet use and score 50 or above on the Internet Addiction Test (IAT), indicating at least a moderate level of PIU;
- own a personal smartphone or other electronic communication device to ensure accessibility to digital intervention components;
- provide written informed consent prior to enrollment.
You may not qualify if:
- a self-reported history of substance use (excluding tobacco and alcohol) within the past 12 months;
- current or previous participation in any form of psychotherapy for PIU;
- the presence of severe physical or neurological conditions (e.g., organic brain diseases, history of traumatic brain injury, or coma);
- a self-reported history of diagnosed psychiatric disorders (e.g., schizophrenia, bipolar disorder).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 360000, China
Zhejiang University
Hangzhou, Zhejiang, 360000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants and therapists cannot be blinded due to the nature of psychotherapy. Outcome assessors and data analysts will remain blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2026
First Posted
February 27, 2026
Study Start
March 17, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
August 5, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Beginning immediately after publication of the primary trial results and ending 5 years thereafter.
- Access Criteria
- Researchers seeking access should submit a methodologically sound research proposal and statistical analysis plan to the principal investigator. Requests will be evaluated on the basis of scientific merit, feasibility, consistency with participant consent, and compliance with applicable ethical and data-protection requirements. Approved requesters will be required to sign a data-use agreement, and the data may be used only for the analyses specified in the approved proposal.
Deidentified individual participant data underlying the results reported in the primary and secondary trial publications, together with a data dictionary, will be made available upon reasonable request. Data will be available beginning after publication of the primary trial results and for 5 years. Requests must include a scientifically sound research proposal and statistical analysis plan and will be reviewed by the principal investigator and study team. Access will be subject to participant consent, applicable ethical and data-protection requirements, and execution of a data-use agreement. Approved data will be provided only for the analyses specified in the accepted proposal.